Troponin News and Research

RSS
New high-sensitive blood test may help predict risk of heart failure in older people

New high-sensitive blood test may help predict risk of heart failure in older people

cTnT blood biomarker may predict risk of cardiovascular problems: Study

cTnT blood biomarker may predict risk of cardiovascular problems: Study

Roche Diagnostics introduces STAT immunoassays for cardiac biomarker testing

Roche Diagnostics introduces STAT immunoassays for cardiac biomarker testing

Running continuously over 50 or 100 miles may not be good for the heart: Study

Running continuously over 50 or 100 miles may not be good for the heart: Study

Improvement of postoperative care decreases myocardial ischemia and major cardiac events

Improvement of postoperative care decreases myocardial ischemia and major cardiac events

Abbot's innovative solutions to be highlighted at AACC

Abbot's innovative solutions to be highlighted at AACC

CardioGenics Holdings' subsidiary signs second product agreement with Merck Chimie

CardioGenics Holdings' subsidiary signs second product agreement with Merck Chimie

CardioGenics announces clinical test sites for QL Care portable blood analyzer

CardioGenics announces clinical test sites for QL Care portable blood analyzer

2,300 researchers under one roof at American Society of Echocardiography 21st Annual Scientific Sessions

2,300 researchers under one roof at American Society of Echocardiography 21st Annual Scientific Sessions

OXiGENE reports positive final data from Phase 1 study of OXi4503 in patients with solid tumors

OXiGENE reports positive final data from Phase 1 study of OXi4503 in patients with solid tumors

Data on Nanosphere Verisens PSA assay to be presented at AUA annual meeting

Data on Nanosphere Verisens PSA assay to be presented at AUA annual meeting

Cardiola's m.pulse MCP based system improves cardiac function in stable CHF patients

Cardiola's m.pulse MCP based system improves cardiac function in stable CHF patients

Ischemix commences CMX-2043 Phase 2a trial for prevention of peri-operative ischemia-reperfusion injury

Ischemix commences CMX-2043 Phase 2a trial for prevention of peri-operative ischemia-reperfusion injury

Cardiac marker POC test: A successful concept of point-of-care diagnostics

Cardiac marker POC test: A successful concept of point-of-care diagnostics

Cardiac myosin-binding protein C identified as potential new diagnostic biomarker for heart attacks

Cardiac myosin-binding protein C identified as potential new diagnostic biomarker for heart attacks

New IME-developed cardiac biomarker testing system saves time

New IME-developed cardiac biomarker testing system saves time

Non-clinical data of CK-2017357 presented by Cytokinetics

Non-clinical data of CK-2017357 presented by Cytokinetics

Study reveals high levels of cardiac biomarkers in the blood of heart attack patients

Study reveals high levels of cardiac biomarkers in the blood of heart attack patients

Results from Phase IIa clinical trial evaluating VT-111 reported by Viron Therapeutics

Results from Phase IIa clinical trial evaluating VT-111 reported by Viron Therapeutics

Financial results for third-quarter 2009 announced by Spectral Diagnostics

Financial results for third-quarter 2009 announced by Spectral Diagnostics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.